Mercury in the human adrenal medulla could contribute to increased plasma noradrenaline in aging

Plasma noradrenaline levels increase with aging, and this could contribute to the sympathetic overactivity that is associated with essential hypertension and the metabolic syndrome. The underlying cause of this rise in noradrenaline is unknown, but a clue may be that mercury increases noradrenaline output from the adrenal medulla of experimental animals. We therefore determined the proportion of people from 2 to 104 years of age who had mercury in their adrenal medulla. Mercury was detected in paraffin sections of autopsied adrenal glands using two methods of elemental bioimaging, autometallography and laser ablation-inductively coupled plasma-mass spectrometry. Mercury first appeared in cells of the adrenal medulla in the 21-40 years group, where it was present in 52% of samples, and increased progressively in frequency in older age groups, until it was detected in 90% of samples from people aged over 80 years. In conclusion, the proportion of people having mercury in their adrenal medulla increases with aging. Mercury could alter the metabolism of catecholamines in the adrenal medulla that leads to the raised levels of plasma noradrenaline in aging. This retrospective autopsy study was not able to provide a definitive link between adrenal mercury, noradrenaline levels and hypertension, but future functional human and experimental studies could provide further evidence for these associations.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Scientific reports - 11(2021), 1 vom: 03. Feb., Seite 2961

Sprache:

Englisch

Beteiligte Personen:

Pamphlett, Roger [VerfasserIn]
Kum Jew, Stephen [VerfasserIn]
Doble, Philip A [VerfasserIn]
Bishop, David P [VerfasserIn]

Links:

Volltext

Themen:

FXS1BY2PGL
Journal Article
Mercury
Norepinephrine
Research Support, Non-U.S. Gov't
X4W3ENH1CV

Anmerkungen:

Date Completed 12.11.2021

Date Revised 12.11.2021

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-021-82483-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM320972755